Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Color and Odor Testing – V 2.0

Posted on By

Elixir Department: SOP for Color and Odor Testing – V 2.0

Standard Operating Procedure for Color and Odor Testing of Elixir Formulations

Department Elixir Department
SOP No. SOP/ELX/221/2025
Supersedes SOP/ELX/221/2022
Page No. Page 1 of 7
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To describe the procedure for evaluating the color and odor of elixir formulations during in-process checks and final product release to ensure consistency with approved specifications and organoleptic properties.

2. Scope

This SOP is applicable to the Quality Control Department for assessing the color and odor of elixir products as part of routine quality evaluation.

3. Responsibilities

  • QC Analyst:
    • Perform the organoleptic evaluation and record observations accurately.
  • QC Supervisor:
    • Verify the observations and compare against reference standards or historical data.
  • QA Officer:
    • Ensure specifications are met and results are reviewed prior to batch release.
See also  Elixir Department: SOP for Use of Controlled Atmosphere During Mixing - V 2.0

4. Accountability

The QC Head is accountable for ensuring accurate execution of this SOP. The QA Head is responsible for ensuring organoleptic consistency and final batch disposition.

5. Procedure

5.1 Sample Preparation

  1. Take a representative sample of the
elixir (approx. 20–30 mL).
  • Use a clean, transparent glass container with a wide opening.
  • Ensure the sample is at room temperature (25 ± 2°C).
  • 5.2 Color Evaluation

    1. Observe the sample in natural or white light against a white background.
    2. Compare with the product specification or reference standard (if available).
    3. Note any deviation from expected appearance:
      • Color change (e.g., darkening, fading, precipitation)
      • Presence of haze or turbidity
    4. Record the color as per the descriptor (e.g., transparent pink, amber, clear green).

    5.3 Odor Evaluation

    1. Immediately after removing the cap, gently waft air above the container toward your nose (do not inhale directly).
    2. Assess for:
      • Characteristic aroma as defined in formulation (e.g., minty, fruity, alcoholic)
      • Any off-odors (e.g., rancid, sulfurous, medicinal)
    3. If off-odor is suspected, have a second analyst confirm and report to supervisor.

    5.4 Acceptance Criteria

    1. Color: Should match the specification or approved reference standard for that formulation.
    2. Odor: Should be acceptable, pleasant, and characteristic of the flavoring agent used.
    3. Any deviation must be documented and investigated as per deviation SOP.

    5.5 Documentation

    1. Record observations in the Color and Odor Evaluation Logbook (Annexure-1).
    2. Include batch number, product name, date, result, and analyst signature.

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • QC: Quality Control
    • QA: Quality Assurance

    7. Documents

    1. Color and Odor Evaluation Logbook (Annexure-1)
    2. Reference Standard Register (if applicable)
    3. Batch Manufacturing Record (BMR)

    8. References

    • 21 CFR Part 211.160 – Laboratory Controls
    • ICH Q6A – Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and Products

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Color and Odor Evaluation Logbook

    Date Batch No. Color Observed Odor Observed Specification Match Tested By Verified By
    11/04/2025 ELX-0425-039 Clear pale pink Fruity Yes Rajesh Kumar Sunita Reddy

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 1.0 Initial SOP Release New SOP QA Head
    11/04/2025 2.0 Clarified evaluation descriptors and documentation fields GMP Enhancement QA Head
    See also  Elixir Department: SOP for Statistical Trending of IPC Data - V 2.0
    Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

    Post navigation

    Previous Post: Lessons Learned from FDA 483s on Poor SOP Revision Practices
    Next Post: Analytical Method Development: SOP for Dissolution Method for Coated Beads in Capsules – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version